Oxidative and antioxidative balance in patients of migraine

European Review for Medical and Pharmacological Sciences

Volumn 14, Issue 10, 2010, Pages 877-882

  Alp, Recep ^a   Selek, S ^a   Ilhan Alp, S ^a   Taskin A ^b   Kocyigit A ^b  

^a KAFKAS UNIVERSITY   (Turkey)

^b HARRAN UNIVERSITY   (Turkey)

Author keywords

Antioxidants; Headache; Migraine; Oxidative stress; Oxidative stress index

Indexed keywords

ANTIOXIDANT; OXIDIZING AGENT; REACTIVE OXYGEN METABOLITE; TROLOX C;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD CHEMISTRY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE DURATION; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE WITHOUT AURA; OXIDATION; OXIDATIVE STRESS; OXIDATIVE STRESS INDEX; METABOLISM; MIGRAINE;

ADULT; ANTIOXIDANTS; FEMALE; HUMANS; MALE; MIGRAINE DISORDERS; OXIDATIVE STRESS;

EID: 79952207495     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. WELCH KM, CUTRER FM, GOADSBY PJ. Migraine pathogenesis: Neural and vascular mechanisms. Neurology 2003; 60: 9-14.
2. GOADSBY PJ. Recent advances in understanding migraine mechanisms, molecules and therapeutics. Trends Mol Med 2006; 13: 39-44.
3. SPARACO M, FELEPPA M, LIPTON RB, RAPOPORT AM, BIGAL ME. Mitochondrial dysfunction and migraine: evidence and hypotheses. Cephalalgia 2005; 25: 361-372.
4. HALLIWELL B, GUTTERIDGE JMC, EDITORS. Free radicals in biology and medicine, 3rd ed. Oxford7 Oxford Science Publications; 2000.
5. YOUNG IS, WOODSIDE JV. Antioxidants in health and disease. J Clin Pathol 2001; 54: 176-186.
6. BOCKOWSKI L, SOBANIEC W, KULAK W, SEMIGIELSKA-KUZIA J. Serum and intraerythrocyte antioxidant enzymes and lipid peroxides in children with migraine. Pharmacol Rep 2008; 60: 542-548.
7. SHUKLA R, BARTHWAL MK, SRIVASTAVA N, SHARMA P, RAGHAVAN SA, NAG D, SRIMAL RC, SETH PK, DIKSHIT M. Neutrophil-free radical generation and enzymatic antioxidants in migraine patients. Cephalalgia 2004; 24: 37-43.
8. TOZZI-CIANCARELLI MG, DE MATTEIS G, DI MASSIMO C, MARINI C, CIANCARELLI I, CAROLEI A. Oxidative stress and platelet responsiveness in migraine. Cephalalgia 1997; 17: 580-584.
9. SHIMOMURA T, KOWA H, NAKANO T, KITANO A, MARUKAWA H, URAKAMI K, TAKAHASHI K. Platelet superoxide dismutase in migraine and tension-type headache. Cephalalgia 1994; 14: 215-218.
10. CIANCARELLI I, TOZZI-CIANCARELLI MG, DI MASSIMO C, MARINI C, CAROLEI A. Urinary nitric oxide metabolites and lipid peroxidation by products in migraine. Cephalalgia 2003; 23: 39-42.
11. TUNCEL D, TOLUN IF, GOKCE M, IMREK S, EKERBICER H. Oxidative stress in migraine with and without aura. Biol Trace Elem Res 2008; 126: 92-97.
12. EREL O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004; 37: 112-119.
13. HEADACHE CLASSIFICATION SUBCOMMITTEE OF THE INTERNATIONAL HEADACHE SOCIETY. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004; 24(suppl 1):9-160.
14. STEWART WF, LIPTON RB, DOWSON AJ, SAWYER J. Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology 2001; 56(6 Suppl 1): 20-28.
15. EREL O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005; 38: 1103-1111.
16. YENI E, GULUM M, SELEK S, EREL O, UNAL D, VERIT A, SAVAS M. Comparison of oxidative/ant oxidative status of penile corpus cavernosum blood and peripheral venous blood. Int J Impot Res 2005; 17: 19-22.
17. HARMA M, HARMA M, EREL O. Increased oxidative stress in patients with hydatidiform mole. Swiss Med Wkly 2003; 133: 563-536.
18. YANIK M, EREL O, KATI M. The relationship between potency of oxidative stress and severity of depression. Acta Neuropsychiatr 2004; 16: 200-203.
19. HU ML, LOUIE S, CROSS CE, MOTCHNIK P, HALLIWELL B. Antioxidant protection against hypochlorous acid in human plasma. J Lab Clin Med 1993; 121: 257-261.
20. MOSKOWITZ MA, BUZZI MG, SAKAS DE, LINNIK MD. Pain mechanisms underlying vascular headaches: Progress Report 1989. Rev Neurol 1989; 145: 181-193.
21. REUTER U, SANCHEZ DEL RIO M, MOSKOWITZ M. Experimental models of migraine. Funct Neurol 2000; 15: 9-18.
22. GOADSBY PJ, EDVINSSON L, EKMAN R. Release of vasoactive peptides in the extracerebral circulation of man and the cat during activation of the trigeminovascular system. Ann Neurol 1988; 23: 193-196.
23. BLAKE GI, RIDKER PM. Novel clinical markers of vascular wall inflammation. Circ Res 2001; 89: 763-771.
24. MUNNO I, CENTONZE V, MARINARO M, BASSI A, LACEDRA G, CAUSARANO V, NARDELLI P, CASSIANO MA, ALBANO O. Cytokines and migraine: increase of IL-5 and IL-4 plasma levels. Headache 1998; 38: 465-467.
25. SARCHIELLI P, ALBERTI A, BALDI A, COPPOLA F, ROSSI C, PIERGUIDI L, FLORIDI A, CALABRESI P. Proinflammatory cytokines, adhesion molecules and lymphocyte integrin expression in the internal jugular blood of migraine patients without aura assessed ictally. Headache 2006; 46: 200-207.
26. LANCE J. Current concepts of migraine pathogenesis. Neurology 1993; 43: 11-15.
27. PASAOGLU H, SANCAK B, BUKAN N. Lipid peroxidation and resistance to oxidation in patients with type 2 diabetes mellitus. Tohoku J Exp Med 2004; 203: 211-218.
28. ALTINDAG O, EREL O, AKSOY N, SELEK S, CELIK H, KARAOGLANOGLU M. Increased oxidative stress and its relation with collagen metabolism in knee osteoarthritis. Rheumatol Int 2007; 27: 339-344.